SCI Foundation is now Unlimit Health. Learn more about what the change means for our ongoing efforts to eliminate neglected tropical diseases

Unlimit Health logo

In 2022, Unlimit Health was awarded the status of Independent Research Organisation (IRO) by UK Research and Innovation (UKRI), the body responsible for convening the UK’s research councils and for supporting research, knowledge exchange and innovation.

This is an important step in Unlimit Health’s commitment to operate as an evidence-based organisation and enhance our dedication to academic research and programmes that reflect the needs and priorities of our partners.

Current projects

Developing a suitable formulation to treat infants and preschool-aged children affected by schistosomiasis.

ADOPT programme

Determining the optimal sampling approach to assess the prevalence of schistosomiasis and guide treatment decisions.

SOS project

Past projects

Improving adolescent girls’ and women’s health by reducing morbidity associated with female genital schistosomiasis (FGS).

FAST research project

A community-driven approach to plan environmental and behavioural actions to reduce the transmission of schistosomiasis.

Uganda community-led pilot

Understanding the impact of existing schistosomiasis control programmes on pork tapeworm (Taenia solium) in Uganda.

Pork tapeworm (Taenia Solium) research

Integrating preventive treatment for female genital schistosomiasis into the national health system.

FGS prevention in Côte d’Ivoire

UK Aid working to fight neglected tropical diseases (NTDs) in West and Central Africa.

Ascend programme

Identifying meaningful and measurable targets for the control of schistosomiasis-related morbidity in Africa.

MORBID pilot

Enhancing access to treatment for neglected tropical diseases among refugee populations.

Promoting NTD treatment access for refugees

A method to evaluate and tackle concerns with official population data within NTD programmes.

SAPIENs project